Steven Hoerter

Mr. Steven L.
Hoerter is an Executive Chairman at MBX Biosciences, Inc., an Independent Director at C4 Therapeutics, Inc. and an Independent Director at Oric Pharmaceuticals, Inc. He is on the Board of Directors at C4 Therapeutics, Inc., Oric Pharmaceuticals, Inc. and Yarrow Bioscience, Inc. /New/.
Mr. Hoerter was previously employed as an Independent Director by Constellation Pharmaceuticals, Inc., a President & Chief Executive Officer by Deciphera Pharmaceuticals, Inc., an Independent Director by Ignyta, Inc., a Chief Commercial Officer by Agios Pharmaceuticals, Inc., an Independent Director by Constellation Pharmaceuticals, Inc., a Chief Commercial Officer & Executive VP by Clovis Oncology, Inc., a Director-Pipeline Development by Genentech, Inc., a President & Chief Executive Officer by Deciphera Pharmaceuticals LLC, and a GM, Head-Sub-Saharan Africa & Indian Ocean Region by Roche Group.
He received his undergraduate degree from Bucknell University, a graduate degree from Krannert School of Management and an MBA from the University of Tilburg.